EconPapers    
Economics at your fingertips  
 

Are novel drugs more risky for patients than less novel drugs?

Mary Olson

Journal of Health Economics, 2004, vol. 23, issue 6, 1135-1158

Date: 2004
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (14) Track citations by RSS feed

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0167-6296(04)00084-0
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:jhecon:v:23:y:2004:i:6:p:1135-1158

Access Statistics for this article

Journal of Health Economics is currently edited by J. P. Newhouse, A. J. Culyer, R. Frank, K. Claxton and T. McGuire

More articles in Journal of Health Economics from Elsevier
Bibliographic data for series maintained by Haili He ().

 
Page updated 2021-01-08
Handle: RePEc:eee:jhecon:v:23:y:2004:i:6:p:1135-1158